Testing the Addition of Darolutamide to Hormonal Therapy (Androgen Deprivation Therapy [ADT]) After Surgery for Men With High-Risk Prostate Cancer, The ERADICATE Study
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Alicia K Morgans
ECOG-ACRIN Cancer Research Group
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
115 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- City of Hope Comprehensive Cancer Center
Duarte, California, United States
- Los Angeles County-Usc Medical Center
Los Angeles, California, United States
- Usc / Norris Comprehensive Cancer Center
Los Angeles, California, United States
- Stanford Cancer Institute Palo Alto
Palo Alto, California, United States
- Va Palo Alto Health Care System
Palo Alto, California, United States
- City of Hope South Pasadena
South Pasadena, California, United States
- City of Hope Upland
Upland, California, United States
- Hartford Hospital
Hartford, Connecticut, United States
- Genesiscare Usa - Lakewood Ranch
Lakewood Rch, Florida, United States
- Mount Sinai Medical Center
Miami Beach, Florida, United States
- Genesiscare Usa - Plantation
Plantation, Florida, United States
- Hawaii Cancer Care Inc - Waterfront Plaza
Honolulu, Hawaii, United States
- Queen'S Cancer Cenrer - Pob I
Honolulu, Hawaii, United States
- Queen'S Cancer Center - Kuakini
Honolulu, Hawaii, United States
- Queen'S Medical Center
Honolulu, Hawaii, United States
- Straub Clinic and Hospital
Honolulu, Hawaii, United States
- the Cancer Center of Hawaii-Liliha
Honolulu, Hawaii, United States
- Pali Momi Medical Center
‘Aiea, Hawaii, United States
- Rush - Copley Medical Center
Aurora, Illinois, United States
- Illinois Cancercare-Bloomington
Bloomington, Illinois, United States
- Illinois Cancercare-Canton
Canton, Illinois, United States
- Illinois Cancercare-Carthage
Carthage, Illinois, United States
- Northwestern University
Chicago, Illinois, United States
- University of Chicago Comprehensive Cancer Center
Chicago, Illinois, United States
- Carle on Vermilion
Danville, Illinois, United States
- Cancer Care Specialists of Illinois - Decatur
Decatur, Illinois, United States
- Decatur Memorial Hospital
Decatur, Illinois, United States
- Carle Physician Group-Effingham
Effingham, Illinois, United States
- Crossroads Cancer Center
Effingham, Illinois, United States
- Elmhurst Memorial Hospital
Elmhurst, Illinois, United States
- Illinois Cancercare-Eureka
Eureka, Illinois, United States
- Northshore University Healthsystem-Evanston Hospital
Evanston, Illinois, United States
- Illinois Cancercare-Galesburg
Galesburg, Illinois, United States
- Northshore University Healthsystem-Glenbrook Hospital
Glenview, Illinois, United States
- Northshore University Healthsystem-Highland Park Hospital
Highland Park, Illinois, United States
- Illinois Cancercare-Kewanee Clinic
Kewanee, Illinois, United States
- Northwestern Medicine Lake Forest Hospital
Lake Forest, Illinois, United States
- Illinois Cancercare-Macomb
Macomb, Illinois, United States
- Carle Physician Group-Mattoon/charleston
Mattoon, Illinois, United States
- Edward Hospital/cancer Center
Naperville, Illinois, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 1 Mar 2021
- Primary completion
- 30 Sept 2026
- Completion
- 31 May 2028
- Last update posted
- 29 Jun 2026
- Registered enrollment
- 27
- Registry id
- NCT04484818
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.